1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING INTEREST ON MEDICAL AESTHETIC TREATMENTS
3.2.2. ALTERATION FROM INVASIVE TO NON-INVASIVE TECHNIQUES
3.2.3. INCREASE IN MEDICAL AESTHETIC PROCEDURES
3.2.4. GROWING DEMAND FOR MINIMALLY INVASIVE RECONSTRUCTION SURGERIES
3.2.5. GROWING ADOPTION OF HOME-USE AESTHETIC DEVICES
3.2.6. TECHNOLOGICAL ADVANCEMENTS
3.3. KEY RESTRAINTS
3.3.1. EXPENSIVE IMPLANTABLE MEDICAL DEVICES
3.3.2. ADVERSE EFFECTS OF MEDICAL AESTHETICS
3.3.3. RISK OF MALFUNCTIONS
3.3.4. LACK OF REIMBURSEMENT
3.3.5. THREAT OF COUNTERFEIT PRODUCTS

4. KEY ANALYTICS
4.1. PORTER'S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER'S POWER
4.1.4. SUPPLIER'S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. VALUE CHAIN ANALYSIS
4.3. REGULATORY FRAMEWORK
4.4. IMPACT OF COVID-19 ON MEDICAL AESTHETICS PROCEDURES
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT
5.1. DEVICES
5.1.1. AESTHETIC LASER
5.1.2. SKIN TIGHTENING & BODY CONTOURING DEVICES
5.2. IMPLANTS
5.2.1. DENTAL IMPLANTS
5.2.2. BREAST IMPLANTS
5.2.3. FACIAL IMPLANT
5.2.4. OTHER IMPLANTS

6. MARKET BY APPLICATION
6.1. SURGICAL
6.2. NON-SURGICAL

7. MARKET BY END-USER
7.1. HOSPITALS & CLINICS
7.2. MEDICAL SPAS & BEAUTY CENTERS

8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA

9. COMPANY PROFILES
9.1. MERZ PHARMA GMBH & CO KGAA
9.2. SYNERON MEDICAL (SYNERON CANDELA)
9.3. LUMENIS
9.4. ALLERGAN PLC
9.5. IPSEN
9.6. CUTERA
9.7. CYNOSURE
9.8. JOHNSON & JOHNSON
9.9. SIENTRA INC
9.10. GALDERMA
9.11. INMODE (PREVIOUSLY INVASIX )
9.12. STRAUMANN HOLDING AG
9.13. ZIMMER BIOMET HOLDINGS INC